The new multidisciplinary open access journal for scientifically rigorous research in the life and medical sciences

Re:GEN Open combines the dynamic, global media presence of Genetic Engineering & Biotechnology News (GEN) with the scientific peer-reviewed publishing expertise of Mary Ann Liebert, Inc. to deliver an unprecedented publishing experience: best-in-class author services, rapid and fair peer review, and international exposure for your work.

basic biomedical research
translational biomedical research
Synthetic and Systems Biology
regenerative medicine
cancer research
drug development
cell and gene therapy
infectious disease

The only choice for your next manuscript

The things that matter to you are the things that matter to us: speed, credibility, authority, visibility, and discoverability.

Re:GEN Open is the home for your next manuscript.

Submit Your Manuscript


01 Apr 2021

Call for Editorial Board Members

We are recruiting Editorial Board Members to join Re:GEN Open! If you are interested in giving back to the scientific community and have a scientific background in the life or medical sciences, please contact for more information.

Latest Articles

Oct 22, 2021
The Circulating Level of Noncoding RNA for Breast Cancer Diagnosis—A Meta-Analysis
Miao Wang, Guohui Li, Ranru Wei, Zhaojun Jia, Yao Gu, Aman Sattout, Jie Zhang, and Feng Zhao
Oct 22, 2021
Efficacy and Tolerability of a New Latanoprost 0.005% BAK-Free Nanoemulsion: A Nonrandomized Open-Label Trial
Javier F. Casiraghi, Daniel Grigera, J. Alejo Peyret, Melina del Papa, and María Silvia Passerini
Oct 20, 2021
Acanthamoeba Keratitis: Developing a Novel Contact Lens Disinfectant Remains an Unmet Need
Ruqaiyyah Siddiqui, Mustafa Khamis, Taleb Ibrahim, and Naveed Ahmed Khan
Oct 19, 2021
P13K/AKT/mTOR Pathway-Based Novel Biomarkers for Breast Cancer
Varruchi Sharma, Anil Panwar, and Anil K. Sharma
Oct 14, 2021
Prime Editing, a Novel Genome-Editing Tool That May Surpass Conventional CRISPR-Cas9
Adriana Ochoa-Sanchez, Gabriela Perez-Sanchez, A. Marianna Torres-Ledesma, Juan Pablo R. Valdez, Gabriel Rinaldi, Bárbara B. Moguel, and Christian Molina-Aguilar
Sep 28, 2021
Same Week: Feasibility of Rapid Antiretroviral Initiation in Brazil
Elaine Monteiro Matsuda, Isabela Penteriche de Oliveira, Valeria Oliveira Silva, Cintia Mayumi Ahagon, Ivana Barros de Campos, Daniela Rodrigues Colpas, Fernanda Matsuda Manzoni, and Luís Fernando de Macedo Brígido
Sep 22, 2021
CRISPR Knock-in Designer: Automatic Oligonucleotide Design Software to Introduce Point Mutations by Gene Editing Methods
Sergey V. Prykhozhij, Vinothkumar Rajan, Kevin Ban, and Jason N. Berman